Referrals, Leads, and Solicitation: Where IRDAI Draws the Line in Insurance Distribution

Every partner programme in Indian insurance distribution stands or falls on a single distinction: the difference between passing a lead and soliciting insurance. Get it right and a platform, a lender, a car dealer, or a DSA network can build a legitimate referral business. Get it wrong and the same activity becomes unlicensed distribution, exposing both the unlicensed party and the licensed insurer or intermediary that paid it.

The organising principle of Indian insurance distribution is that only a registered person may solicit and procure insurance. Agents, corporate agents, brokers, insurance marketing firms, web aggregators, and point-of-sales persons are registered precisely so they can solicit; everyone else cannot. Solicitation is not a defined act with a bright edge, which is exactly why it causes so much trouble, but its core is recognisable: approaching a prospect to persuade them to buy a particular insurance product, describing or recommending that product, advising on suitability, or negotiating its terms. Do any of those without a licence and you have solicited without authority.

A referral, by contrast, stops short of solicitation. A referral partner introduces a person to a licensed distributor, or passes a contact, without themselves persuading, describing, recommending, or advising. The referral partner is a bridge to the licensed channel, not a seller.

This post maps the grey zone for the people who need it most: platforms embedding insurance, lenders and retailers referring customers, DSA networks, and brokers designing partner programmes. The through-line is simple: the label on the arrangement does not protect it; the substance does.

The safe zone for an unlicensed referral partner is narrower than most partner-programme decks assume, and describing it precisely is the whole game.

An unlicensed referrer can, broadly, do things that stop short of soliciting:

• Introduce or pass a contact. Give a licensed distributor the name and contact details of a person who has agreed to be approached, so the licensed party makes the actual approach.
• Display or host neutral information. Provide space, or display an insurer's or intermediary's own approved material, without adding advice or a recommendation of their own.
• Make customers aware that insurance is available through a licensed partner, without describing the product's benefits, comparing options, or urging a purchase.

What the same referrer cannot do is the part that partner programmes constantly drift into:

• Describe or explain the product in a way that promotes it.
• Recommend or advise that the person should buy it, or which option to choose.
• Handle the sale, collect the proposal, quote a premium, or negotiate terms.
• Field product questions and answer them substantively, because answering "is this the right cover for me?" is advice.

The test that keeps a referrer safe is whether the licensed party does all the actual selling. If the referrer's role ends at a genuine introduction and the licensed distributor performs the solicitation and closing, the arrangement can be a referral. The moment the referrer's staff start explaining benefits, comparing insurers, or persuading, they have stepped into solicitation, whatever the contract calls them.

Behind the solicitation line sits a hard statutory rule that decides most referral disputes, and it is worth stating plainly because it is often ignored in partner-programme economics.

Section 40 of the Insurance Act, 1938 prohibits the payment of commission or remuneration for soliciting or procuring insurance business to any person who is not a duly authorised or registered insurance agent or intermediary. In other words, you cannot lawfully pay someone for selling insurance unless they are licensed to sell it. This is the provision that turns a mislabelled referral fee into a violation: if the payment is, in substance, remuneration for procuring insurance business, and the recipient is unlicensed, the payment is prohibited regardless of what the invoice says.

Alongside it, Section 41 of the Insurance Act, 1938 prohibits rebating: offering, as an inducement to take out or renew a policy, any rebate of commission or of the premium shown on the policy. Section 41 reaches inducements flowing toward the customer, and carries a fine that may extend to a substantial amount after the 2015 amendment. Referral programmes that reward the customer for buying, or that pass commission to an unlicensed introducer who rebates it, run into one or both sections.

The combined effect is a fence around distribution economics: money paid for procuring insurance may go only to the licensed, and money may not be a rebate to induce a purchase. A genuine referral fee sits outside the fence only if it is genuinely not remuneration for procuring, meaning it is not a per-policy success fee. The closer a payment gets to a commission on policies sold, the harder it is to defend as anything but remuneration for procurement, which Section 40 reserves to the licensed.

The referral question has a specific history in the bank and large-entity context, and understanding it prevents a common error, assuming the old database-sharing referral model still works as it once did.

There was a period when a bank or large entity could enter a referral arrangement built on sharing its customer database with an insurer for a fee, without becoming a licensed distributor. A framework governed such database-sharing under defined conditions. That pure database-referral model has been curtailed, and the mainstream route for a bank to distribute insurance is now to hold a corporate agency registration and distribute as a licensed intermediary, subject to the conduct, disclosure, and remuneration rules for corporate agents.

The shift matters because it closed the gap that the referral model exploited. Under the old approach, an entity could earn from insurance sold to its customers while standing outside the licensing and conduct regime by characterising its role as mere referral. The move to corporate agency brought that activity inside the regime: if a bank is going to earn from insurance distributed to its customers, it does so as a licensed, regulated distributor, accountable for the conduct of that distribution.

For any large entity contemplating monetising its customer base through insurance, the lesson is direct: the scale that makes a database-referral arrangement lucrative is exactly what draws it toward being, in substance, distribution, and substance is what the regime tests. An entity that wants to earn meaningfully from insurance sold to its customers should expect to need a licence, rather than relying on a referral characterisation the framework has narrowed.

Digital distribution created a whole category of businesses whose product is the lead, and IRDAI has a licensed channel for exactly that, which tells you that lead generation for insurance, done at scale and for reward, is regulated activity rather than free-for-all marketing.

The web aggregator is the licensed vehicle for comparison-and-lead businesses. A registered web aggregator can display and compare insurers' products, generate leads, and transmit them to insurers or intermediaries, subject to conditions including on the remuneration it may earn per lead or transaction. A business whose model is generating insurance leads at scale and being paid for them is operating in territory IRDAI regulates through registration, not outside it.

The implication for an unlicensed platform is that the volume and the payment structure of its lead activity matter. Passing an occasional genuine introduction is one thing. Running an at-scale operation that systematically generates insurance leads and is paid per lead or per conversion looks, in substance, like the licensed lead-generation activity the web aggregator regime governs, and characterising it as ordinary marketing does not change what it is. A platform building a real insurance lead business should assess whether it needs a web aggregator or other registration rather than assuming lead generation is unregulated because no one is technically signing a proposal on its site.

The conduct rules that attach to licensed lead generation, on how products are displayed and compared and on not misleading the prospect, are instructive for anyone in the space, because they signal the standards a regulator expects of any player influencing a prospect's insurance decision.

The phone and the digital channel raise the solicitation question in an acute form, because a telecaller or a chat interface is often doing the very thing, persuading and describing, that requires a licence.

The distance marketing of insurance, covering solicitation and sale through telephone, voice, SMS, and electronic modes, is governed by a conduct framework that addresses who may do it and how. The central point is that the person actually soliciting over the phone, describing and recommending the product, taking the prospect toward a purchase, must be an authorised person in the licensed channel, not an unlicensed telecaller employed by a referral partner. A call centre that generates a genuine, consented introduction and hands off to the licensed distributor is in a different position from one whose agents pitch, explain, and close.

Distance marketing also carries conduct obligations designed to protect the prospect: authorised, consented contact, truthful and non-misleading description, no high-pressure selling, and proper record-keeping of the interaction.

For a platform or DSA network running outbound calling or automated messaging, the design question is precise: at what point does the script cross from introduction into solicitation, and is the person on the line licensed to be there when it does? A programme that lets unlicensed telecallers carry the conversation through description and recommendation has built unlicensed solicitation with a compliance veneer. The safer architecture hands the prospect to the licensed channel when real selling begins, and can show from its records that it did.

The single most important thing to understand about how these rules are enforced is that the regulator reads substance, not labels. A payment called a referral fee, a marketing fee, an infrastructure charge, a technology-support payment, or a lead fee is examined for what it actually is, and if it is in substance remuneration for procuring insurance paid to an unlicensed party, or an inducement caught by the rebating rule, the label does not save it.

The recurring enforcement pattern, visible in IRDAI's public record of warnings and penalties, is the outward payment that traces to distribution the payer was not entitled to reward that way: payments to entities or individuals characterised as something benign that, on examination, correspond to policies procured through an unlicensed channel or function as inducements. The finding lands on the licensed insurer or intermediary that made the payment, because the regime holds the licensed party accountable for keeping distribution inside the licensed perimeter.

Two features of this pattern should shape how a partner programme is designed.

First, the per-policy link is the tell. Payments that scale with policies sold are most readily characterised as remuneration for procurement; a structure that mirrors commission is most likely to be read as commission.

Second, the licensed party carries the exposure. The unlicensed referrer is not the only one at risk; the insurer or intermediary that paid it is squarely in frame, often the primary target. A broker or insurer designing a partner programme is not doing the partner a favour by tolerating a loose structure; it is accepting the enforcement risk itself.

For a platform, DSA network, or broker designing a partner programme that stays on the right side of the line, a working discipline:

1. Decide honestly whether the partner solicits. If the partner's people describe products, recommend cover, answer suitability questions, or close sales, the partner is soliciting and must be licensed, or the activity must move to the licensed channel. Design from what the partner actually does, not from what you would like to call it.
2. Keep the referrer's role to genuine introduction. Limit an unlicensed partner to consented introductions and neutral awareness, and hand the prospect to the licensed distributor at the point real selling begins. Build the hand-off into the process and the systems, not just the policy document.
3. Do not tie the fee to policies sold. A payment that scales with conversions is the structure most readily read as remuneration for procurement. If the partner is unlicensed, structure any payment so it is genuinely not a per-policy success fee for selling, and take advice on whether it survives Section 40 at all.
4. License the activity when it is really distribution. If the partner's role, or your platform's own, is in substance soliciting or generating leads at scale for reward, pursue the right registration rather than a referral characterisation the regime has narrowed.
5. Control the front line. Because programmes drift when incentivised staff start selling, monitor what partner staff actually say and do, script the boundary, and audit against the reality, since it is the reality an enforcement review examines.
6. Remember where the risk lands. As the licensed insurer or intermediary, you carry the exposure for payments that cross the line. Treat the compliance of a partner programme as protection of your own licence, not a concession to the partner.

The honest summary: the referral lane is real but narrow, the rule reserving remuneration to the licensed is hard, and the regulator decides on substance. A programme built to survive is built around a genuine hand-off to the licensed channel and a payment structure that does not pretend an unlicensed seller into a mere introducer.